GC
KIN

Guggenheim Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

Guggenheim Capital’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-75,923
Closed -$696K – 2265
2021
Q2 		$696K Buy
+75,923
New +$442K ﹤0.01% 1672

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Guggenheim Capital's KIN Position: Q3 2021 in Review

Guggenheim Capital sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 75,923 shares — an estimated $696K sold.

Guggenheim Capital first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $696K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Guggenheim Capital reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Guggenheim Capital sold 75,923 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $696K.
  • Guggenheim Capital first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Guggenheim Capital's Kindred Biosciences, Inc. position peaked at $696K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.